CIK: 0001599719 · Show all filings
Period: Q4 2013 (Next →)
Filing Date: Feb 14, 2014
Total Value ($000): $1,284,836 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 3,141,629 | $580,227 | 45.2% | $184.69 | — | TR UNIT | 78462F103 |
| VNQ | VANGUARD INDEX FDS | 2,652,704 | $171,258 | 13.3% | $64.56 | — | REIT ETF | 922908553 |
| XRT | SPDR SERIES TRUST | 1,368,363 | $120,553 | 9.4% | $88.10 | — | S&P RETAIL ETF | 78464A714 |
| EEM | ISHARES | 1,662,723 | $69,493 | 5.4% | $41.79 | — | MSCI EMG MKT ETF | 464287234 |
| — | POWERSHARES QQQ TRUST | 760,983 | $66,936 | 5.2% | $87.96 | — | UNIT SER 1 | 73935A104 |
| XLF | SELECT SECTOR SPDR TR | 2,785,000 | $60,880 | 4.7% | $21.86 | — | SBI INT-FINL | 81369Y605 |
| EPP | ISHARES | 1,181,122 | $55,194 | 4.3% | $46.73 | — | MSCI PAC JP ETF | 464286665 |
| ORA | ORMAT TECHNOLOGIES INC | 1,571,011 | $42,748 | 3.3% | $24.17 | 0.0% | COM | 686688102 |
| FXI | ISHARES | 994,000 | $38,140 | 3.0% | $38.37 | — | CHINA LG-CAP ETF | 464287184 |
| — | ISHARES | 2,980,436 | $36,180 | 2.8% | $12.14 | — | MSCI JAPAN ETF | 464286848 |
| AAXJ | ISHARES | 438,649 | $26,455 | 2.1% | $60.31 | — | MSCI AC ASIA ETF | 464288182 |
| EWA | ISHARES | 176,749 | $4,308 | 0.3% | $24.37 | — | MSCI AUST ETF | 464286103 |
| VWO | VANGUARD INTL EQUITY INDEX F | 96,509 | $3,970 | 0.3% | $41.14 | — | FTSE EMR MKT ETF | 922042858 |
| VPL | VANGUARD INTL EQUITY INDEX F | 58,108 | $3,562 | 0.3% | $61.30 | — | MEGA CAP GRO ETF | 922042866 |
| IVV | ISHARES | 14,050 | $2,608 | 0.2% | $185.62 | — | CORE S&P500 ETF | 464287200 |
| — | PROTALIX BIOTHERAPEUTICS INC | 566,560 | $2,204 | 0.2% | $3.89 | — | COM | 74365A101 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2,987 | $120 | 0.0% | $40.17 | — | ADR | 881624209 |